Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion
Pfizer has agreed to acquire the biotechnology company Merida Biosciences for up to $2.875 billion in cash, with the aim of enhancing the company’s immunological portfolio.
SummaryAI generated
Elliott L. Company announced plans to acquire Murrayda Biologics, with a transaction value of up to 2.875 billion US dollars, aiming to expand its presence in the biopharmaceutical sector.
Related eventsRELATED EVENTS
- 2026-09-04 22:32Nvidia acquired the open-source AI platform Hugging Face for approximately $12.93 billion.
- 2026-09-08 22:17French AI company Mistral received a $3 billion Series D financing led by Samsung, with a valuation of over 21 billion euros
- 2026-09-07 18:49①MIIT: To fully build a new generation of communication network that is comprehensive and advanced in performance; ②Huawei releases the high-performance chip Kirin 9050 Pro after six years; ③Aojie Technology: Alibaba reduced its holdings in the company by 5.2831 million shares from August 17 to September 7.
Key entitiesKEY ENTITIES
Eli LillyMerida Biosciences
Coverage · reports per dayLANGUAGE SPLIT
Entity relations
SignalsSIGNALS
Keyword heat